| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $68,709,695 ) (Continued on the next page) |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA269866 | Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma | 000 | 3 | NIH | 12/13/2024 | $477,217 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL174477 | Critical roles of RNA m5C-MBD6-H2AK119ub deubiquitylation axis in TET2-mediated HSC regulation | 000 | 2 | NIH | 6/6/2025 | $703,040 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI153425 | Defining conserved epitopes on polymorphic malaria antigens | 000 | 5 | NIH | 1/23/2025 | $527,357 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 001 | 4 | NIH | 5/5/2025 | $72,458 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 000 | 4 | NIH | 1/6/2025 | $652,130 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK138035 | Paracrine effects of leptin in regulating visceral fat expansion | 000 | 2 | NIH | 2/27/2025 | $348,750 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK138035 | Paracrine effects of leptin in regulating visceral fat expansion | 001 | 2 | NIH | 6/13/2025 | $38,750 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25NS115552 | Summer Physiology Undergraduate Researcher (SPUR) Program | 000 | 5 | NIH | 11/29/2024 | $107,680 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01ES007061 | Mechanisms of DNA Double-strand Break End Resection and Repair Pathway Choice | 001 | 31 | NIH | 12/16/2024 | $51,484 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01ES007061 | Mechanisms of DNA Double-strand Break End Resection and Repair Pathway Choice | 000 | 31 | NIH | 12/13/2024 | $505,540 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30DE035386 | Control of Virulence Properties in the Major Human Oral Fungal Pathogen Candida albicans by the Asc1 Translational Regulator | 001 | 1 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30DE035386 | Control of Virulence Properties in the Major Human Oral Fungal Pathogen Candida albicans by the Asc1 Translational Regulator | 000 | 1 | NIH | 6/13/2025 | $40,549 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS128574 | Chronic Intermittent Hypoxia and Hyperalgesic Priming | 000 | 3 | NIH | 2/13/2025 | $560,256 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI186304 | Translational Control of Conidial Germination in Aspergillus fumigatus | 000 | 2 | NIH | 4/7/2025 | $232,500 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01EY012085 | Intercellular Communication in the Eye Lens | 000 | 27 | NIH | 12/20/2024 | $419,959 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | T32DA031115 | Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology | 000 | 15 | NIH | 5/22/2025 | $498,195 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI183125 | Dissecting the mechanism of altered immune responses during obesity | 000 | 1 | NIH | 6/20/2025 | $425,647 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133304 | A novel pathway controls liver injury in NASH | 000 | 4 | NIH | 4/16/2025 | $519,180 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 002 | 1 | NIH | 5/22/2025 | $564 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 001 | 1 | NIH | 3/12/2025 | $0 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA298683 | Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress | 000 | 1 | NIH | 3/12/2025 | $41,506 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG082360 | The San Antonio Heart and Mind Study | 001 | 3 | NIH | 6/10/2025 | $288,581 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG082360 | The San Antonio Heart and Mind Study | 000 | 3 | NIH | 3/20/2025 | $3,246,532 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH125979 | Gene editing in the brain with CRISPR-PEG | 000 | 5 | NIH | 2/13/2025 | $567,518 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM128731 | Structure and Function of the Essential Cell Cycle Regulator Cdc34 | 000 | 8 | NIH | 3/3/2025 | $287,372 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 001 | 4 | NIH | 5/22/2025 | $52,646 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA262757 | Enhancing endoplasmic reticulum stress in ovarian cancer | 000 | 4 | NIH | 2/13/2025 | $473,813 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH127216 | Neural connectivity before and after each of the three treatment phases of trauma-focused therapy for adolescent posttraumatic stress | 000 | 4 | NIH | 3/5/2025 | $658,794 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA237159 | Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue | 001 | 6 | NIH | 5/22/2025 | $20,239 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA237159 | Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue | 000 | 6 | NIH | 3/5/2025 | $182,140 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 001 | 3 | NIH | 6/12/2025 | $52,858 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 000 | 3 | NIH | 3/3/2025 | $475,723 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA289167 | Activation of Drug and Biologic Conjugates by Click Chemistry and their Tumor-selective Targeting for Prostate Cancer Suppression | 001 | 2 | NIH | 5/22/2025 | $17,882 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA289167 | Activation of Drug and Biologic Conjugates by Click Chemistry and their Tumor-selective Targeting for Prostate Cancer Suppression | 000 | 2 | NIH | 3/3/2025 | $160,937 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI045050 | Characterization of SLE-susceptibility loci on mouse chromosome 1 | 002 | 25 | NIH | 6/10/2025 | $721,482 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM141631 | Repair of DNA ends with adducts | 000 | 3 | NIH | 2/24/2025 | $279,000 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21DE034099 | Practitioners Approach to Oral Appliance Therapy for Obstructive Sleep Apnea and the Impact on Patients Outcomes | 000 | 1 | NIH | 6/17/2025 | $449,861 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30MH134482 | Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders | 000 | 2 | NIH | 3/17/2025 | $41,812 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30MH134482 | Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders | 001 | 2 | NIH | 3/20/2025 | $500 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD106285 | Pathological reprogramming of the m6A epitranscriptome in uterine fibroids | 001 | 5 | NIH | 4/24/2025 | $647,762 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA246807 | Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy | 000 | 5 | NIH | 3/10/2025 | $321,049 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK097554 | Comparative Effectiveness of Two Initial Combination Therapies in Patients with New Onset Diabetes | 001 | 12 | NIH | 5/14/2025 | $68,490 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK097554 | Comparative Effectiveness of Two Initial Combination Therapies in Patients with New Onset Diabetes | 000 | 12 | NIH | 2/24/2025 | $616,424 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA293672 | Developing purinergic receptor inverse agonists for treating triple negative breast cancer | 000 | 1 | NIH | 2/24/2025 | $616,071 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00AG068239 | Impact of a Novel Secreted Enzyme J18 on Healthspan and Lifespan | 001 | 5 | NIH | 6/9/2025 | $19,920 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00AG068239 | Impact of a Novel Secreted Enzyme J18 on Healthspan and Lifespan | 000 | 5 | NIH | 3/7/2025 | $224,100 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01CA283749 | The role of tumor-macrophage hybrid cells in prostate cancer metastasis | 001 | 2 | NIH | 5/29/2025 | $63,717 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01CA283749 | The role of tumor-macrophage hybrid cells in prostate cancer metastasis | 000 | 2 | NIH | 2/28/2025 | $573,451 |
| | 2025 | 2025 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG061729 | Sulfatide deficiency: A novel mechanism leading to reactive astrogliosis in aging and Alzheimer’s disease | 001 | 3 | NIH | 6/13/2025 | $50,842 |
|
